Sonali Patil is a dedicated Scientist at Five Prime Therapeutics, Inc., where she leverages over eight years of extensive experience in the biotech industry and academic research to drive innovative therapeutic solutions for cancer and other diseases. Her current role involves spearheading projects that utilize...
Sonali Patil is a dedicated Scientist at Five Prime Therapeutics, Inc., where she leverages over eight years of extensive experience in the biotech industry and academic research to drive innovative therapeutic solutions for cancer and other diseases. Her current role involves spearheading projects that utilize cutting-edge technologies, including the proprietary Probody platform, to develop novel T cell bispecific therapeutics. This initiative is particularly noteworthy as it targets previously undruggable cancer targets, showcasing her commitment to pushing the boundaries of what's possible in cancer treatment.
In her capacity as project lead at CytomX Therapeutics, a collaboration with Astellas Pharma, Sonali is responsible for the comprehensive development of the data package necessary for nominating a T cell bispecific as a clinical candidate. Her project management skills are pivotal, as she coordinates multidisciplinary teams to ensure that all aspects of the project—from experimental design to data analysis—are executed seamlessly. Her expertise in cell biology, PCR, and advanced imaging techniques, such as imaging flow cytometry, enables her to contribute significantly to the research and development processes.
Sonali’s proficiency in techniques like siRNA transfection and digital single-cell RT-PCR further enhances her ability to explore complex biological questions and develop innovative solutions. Her passion for scientific research and her collaborative spirit make her a valuable asset to Five Prime Therapeutics, where she continues to make strides in the quest for effective cancer therapies.
